Venture capital deals of the week

16/12/2017 18:43
  • Biotech: Gilead Sciences (NASDAQ:GILD) was a strategic investor in a $59.6M Series C round in Hookipa Biotech. The clinical stage biotech has a cytomegalovirus vaccine in phase 2 and cancer candidates derived from two arenavirus-based vector platforms. Hookipa has raised $100.2M to date, according to Crunchbase. 
  • More news on: Gilead Sciences, Inc., Takeda Pharmaceutical Co., Ltd., Baidu, Inc., Tech stocks news, Healthcare stocks news,
  • Read more ...

More News

Costco Is Anything But Dead

16/12/2017 17:54

After being left for dead earlier in the year when Amazon ( AMZN ) closed its transaction for ...

Teva - Aggressive Cuts Provide Relief

16/12/2017 18:04

In early October I looked at the prospects for Teva ( TEVA ) in an article titled, ¨C...

National Beverage: Tread Carefully - From Both Sides

16/12/2017 18:18

When it comes to the Q2 report from LaCroix sparkling water manufacturer National Beverage ( F...

AVAILABLE FOR DOWNLOAD
AVAILABLE FOR DOWNLOAD
Download our official mobile apps today.
Financial.org is an educational platform. We DO NOT deal with securities and receive any financial benefits from Financial Products & Service Providers.
All Rights Reserved © 2016 - 2018